---
schema_version: "secwatch.filing_event.v1"
accession: "0000021076-22-000015"
form_type: "8-K"
ticker: "CLX"
cik: "0000021076"
company_name: "CLOROX CO /DE/"
filed_at: "2022-05-02T23:59:59+00:00"
generated_at: "2026-06-26T02:12:56.750363+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Clorox Q3 FY2022: Net sales +2% to $1.8B; gross margin down 760 bps; adjusted EPS down 19%

## Summary
- Net sales rose 2% to $1.8B; organic sales also up 2% vs flat prior year.
- Gross margin fell 760 bps to 35.9% on higher manufacturing, logistics, and commodity costs.
- Diluted EPS of $1.21 vs a loss of $0.49; adjusted EPS down 19% to $1.31.
- YTD free cash flow $279M, down 58% from $661M in prior-year period.
- Health & Wellness sales down 3%; Household +6%; Lifestyle +4%; International +1%.

## SEC filing metadata
- accession: 0000021076-22-000015
- form_type: 8-K
- ticker: CLX
- cik: 0000021076
- company_name: CLOROX CO /DE/
- filed_at: 2022-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/21076/000002107622000015/0000021076-22-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/21076/000002107622000015/clx-20220502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000021076-22-000015
- JSON: https://secwatch.observer/filing/0000021076-22-000015.json
- Plain text: https://secwatch.observer/filing/0000021076-22-000015.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.